Key facts
- This page summarizes Mark E. Tryniski's Form 4 filing for CONMED Corp (CNMD).
- 16 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 08 Nov 2021, 19:59.
Mark E. Tryniski - 05 Nov 2021 Form 4 Insider Report for CONMED Corp (CNMD)
- Form type
- 4
- Accepted by SEC
- 08 Nov 2021, 19:59:52 UTC
- Previous filing
- 16 Sep 2021
- Next filing
- 08 Mar 2022
- SEC filing
- View on sec.gov
- Reporting owner signature
- Sarah M Oliker for Mark E. Tryniski by Power of Attorney
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Mark E. Tryniski filed Form 4 for CONMED Corp (CNMD) on 08 Nov 2021.
Change
- Previous filing in this sequence was filed on 16 Sep 2021.
- Current net transaction value: -$1,182,424.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $253,895
- Shares
- +4,892
- Change %
- +59%
- Price
- $51.90
- Shares after
- 13,188
- Date
- 05 Nov 2021
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $749,986
- Shares
- -4,792
- Change %
- -36%
- Price
- $156.51
- Shares after
- 8,396
- Date
- 05 Nov 2021
- Ownership
- Direct
- Footnotes
- F1
CNMD
transaction
Common Stock
Sale
- Transaction value
- $15,711
- Shares
- -100
- Change %
- -1.2%
- Price
- $157.11
- Shares after
- 8,296
- Date
- 05 Nov 2021
- Ownership
- Direct
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $234,633
- Shares
- +3,399
- Change %
- +41%
- Price
- $69.03
- Shares after
- 11,695
- Date
- 05 Nov 2021
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $453,517
- Shares
- -2,899
- Change %
- -25%
- Price
- $156.44
- Shares after
- 8,796
- Date
- 05 Nov 2021
- Ownership
- Direct
- Footnotes
- F2
CNMD
transaction
Common Stock
Sale
- Transaction value
- $78,530
- Shares
- -500
- Change %
- -5.7%
- Price
- $157.06
- Shares after
- 8,296
- Date
- 05 Nov 2021
- Ownership
- Direct
- Footnotes
- F3
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $230,707
- Shares
- +2,886
- Change %
- +35%
- Price
- $79.94
- Shares after
- 11,182
- Date
- 05 Nov 2021
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $373,256
- Shares
- -2,386
- Change %
- -21%
- Price
- $156.44
- Shares after
- 8,796
- Date
- 05 Nov 2021
- Ownership
- Direct
- Footnotes
- F4
CNMD
transaction
Common Stock
Sale
- Transaction value
- $78,474
- Shares
- -500
- Change %
- -5.7%
- Price
- $156.95
- Shares after
- 8,296
- Date
- 05 Nov 2021
- Ownership
- Direct
- Footnotes
- F5
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $136,271
- Shares
- +1,843
- Change %
- +22%
- Price
- $73.94
- Shares after
- 10,139
- Date
- 05 Nov 2021
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $272,750
- Shares
- -1,743
- Change %
- -17%
- Price
- $156.48
- Shares after
- 8,396
- Date
- 05 Nov 2021
- Ownership
- Direct
- Footnotes
- F6
CNMD
transaction
Common Stock
Sale
- Transaction value
- $15,705
- Shares
- -100
- Change %
- -1.2%
- Price
- $157.05
- Shares after
- 8,296
- Date
- 05 Nov 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -4,892
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,892
- Exercise price
- $51.90
- Footnotes
- F7
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -3,399
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,399
- Exercise price
- $69.03
- Footnotes
- F7
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -2,886
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,886
- Exercise price
- $79.94
- Footnotes
- F7
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -1,843
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 05 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,843
- Exercise price
- $73.94
- Footnotes
- F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F7
The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
Footnote F8
The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.